Literature DB >> 15338450

Unusual association of systemic sclerosis and ankylosing spondylitis.

Cinira S Soledade, Percival D Sampaio-Barros, Adil M Samara, João Francisco Marques-Neto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15338450     DOI： 10.1007/s10067-004-0980-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  19 in total

1.  Influence of HLA-B27 on the clinical presentation of psoriatic arthritis.

Authors:  Nicola Dalbeth; Joanne L Dockerty; Lyn Williamson
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

2.  HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.

Authors:  P Langevitz; D Buskila; D D Gladman; G A Darlington; V T Farewell; P Lee
Journal:  Br J Rheumatol       Date:  1992-09

Review 3.  Scleroderma. Clinical problems. The lungs.

Authors:  R M Silver
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients.

Authors:  P D Sampaio-Barros; M B Bertolo; M H Kraemer; J F Neto; A M Samara
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

6.  Early pulmonary involvement in ankylosing spondylitis: assessment with thin-section CT.

Authors:  K Turetschek; W Ebner; D Fleischmann; P Wunderbaldinger; L Erlacher; T Zontsich; A A Bankier
Journal:  Clin Radiol       Date:  2000-08       Impact factor: 2.350

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 8.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

9.  Muscle pathology in ankylosing spondylitis: clinical, enzymatic, electromyographic and histologic correlation.

Authors:  S Faus-Riera; S Martínez-Pardo; J Blanch-Rubió; P Benito-Ruiz; J C Duró-Pujol; J M Corominas-Torres
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

10.  D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.

Authors:  V D Steen; T A Medsger; G P Rodnan
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391
View more
  3 in total

Review 1.  Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review.

Authors:  Avgoustina Kyriakou; Konstantinos Parperis; Elena Nikiphorou; Savvas Psarelis
Journal:  Rheumatol Int       Date:  2021-01-12       Impact factor: 2.631

2.  Sacroiliitis Detected by Magnetic Resonance Imaging in Patients With Systemic Sclerosis.

Authors:  Didem Arslan; İpek Türk; Erkan Kozanoğlu; Özlem Kudaş; Bayram Kelle; Hakan Sakalli
Journal:  Arch Rheumatol       Date:  2020-01-03       Impact factor: 1.472

3.  Patient with ankylosing spondylitis and scleroderma renal crisis.

Authors:  Aliki I Venetsanopoulou; Ourania Argyropoulou; Athanasios G Tzioufas
Journal:  Mediterr J Rheumatol       Date:  2018-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.